Position in BNTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,926,600
+$201,351 QoQ
Shares Held
20,705
+6.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#110
of 282 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GUGGENHEIM CAPITAL LLC holds $210,403,156 across 75 Biotechnology names. BNTX ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
115,233 | $57,239,687 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
45,969 | $28,663,508 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
39,318 | $11,835,897 | |
| 4 | INCY |
Incyte Corp
|
57,780 | $6,549,940 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26,474 | $4,958,050 | |
| 6 | INSM |
INSMED Inc
|
38,766 | $4,133,230 | |
| 7 | MRNA |
Moderna, Inc.
|
55,313 | $3,873,568 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
66,874 | $3,826,530 |
All Filings in BNTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,926,600 | 20,705 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,725,249 | 19,411 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,513,108 | 15,894 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,284,426 | 13,024 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,269,335 | 11,922 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,255,262 | 13,785 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,259,489 | 11,053 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,566,576 | 13,190 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,060,671 | 13,199 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,952,932 | 21,170 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,920,722 | 18,199 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,069,808 | 19,052 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,484,224 | 23,017 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,058,892 | 16,528 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,295,511 | 15,281 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,375,101 | 17,609 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,100,981 | 20,798 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,139,661 | 24,271 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,417,667 | 21,015 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,018,685 | 14,721 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,730,960 | 16,665 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,526,072 | 32,293 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,836,488 | 34,795 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||